StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) income statement

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.56−0.13 (-7.69%)

Close on Nov 20, 2026Market cap $4.36MP/E –Yield –

Processa Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?